ArticleNature communications2026
Cell neighborhood topology directs rare cell population identification.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cell neighborhood topology directs rare cell population identification.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Advances in single-cell and spatial technologies have transformed the dissection of cell composition and tissue architecture in complex biological systems. However, identifying rare cells critical to disease pathogenesis and biological processes remains difficult, as their low abundance often masks them among dominant cell populations. We introduce RareQ, a fast and scalable framework for rare cell detection by evaluating cliquishness of each cell's k-nearest neighborhood using single-cell omics data. Extensive benchmarking on diverse simulated and real datasets demonstrates that RareQ exceeds existing methods in accuracy, sensitivity, and efficiency. RareQ also excels at identifying both modality-specific and shared rare cells. Its versatility across various biological contexts enables the discovery of functionally distinct rare cells with unique molecular signatures in physiological and pathological context. RareQ's application to spatial transcriptomics data reveals anatomically distinct and clinically relevant rare cell populations. Together, RareQ offers an efficient approach for rare cell discovery, enhancing insights into tissue organization and disease mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.